Argenica Therapeutics (ASX:AGN) has achieved another important step in the progression of its Phase 2 trial to assess drug ...

forming the theoretical basis for many of the acute stroke therapies under study (Lees et al., 2006) as well as the rationale for intervening within a therapeutic time window following ischemic ...

A study by Ralph et al. 6 advocates immediate penile prosthesis implantation for the treatment of acute ischemic priapism if medical or surgical attempts at reversal fail. This strategy aims to ...

Medically reviewed by Christopher Lee, MD Ischemia is a condition in which there is insufficient blood flow to a part of the ...

USA: A new study published in Frontiers in Neurology highlights the potential of automatically quantified follow-up imaging ...

The following is a summary of “Effect of sarcopenia on prognosis in patients with mild acute ischemic stroke: a prospective cohort study,” published in the March 2025 issue of BMC Neurology by Chen et ...

A new antibiotic to treat stubborn urinary tract infection (UTI) and a blood-clot-dissolving intravenous treatment for acute ...

Tenecteplase provides comparable safety and effectiveness outcomes for acute ischemic stroke as alteplase, new research ...

Recombinant human prourokinase is noninferior to alteplase in acute ischemic stroke, with symptomatic intracranial hemorrhage and major bleeding decreased.

THURSDAY, March 6, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic ...

Anaconda Biomed, SL, a developer of next-generation neurothrombectomy devices, recently announced the enrollment and ...